DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood g...
DexCom, Inc. (DXCM) has a valuation score of 87/100 (strong), profitability score of 90/100 (strong), financial health score of 93/100 (strong), Piotroski F-Score of 7/9, Altman Z-Score of 7.08 (safe zone), revenue growth of +17.0% YoY.
Neutral
Analyst Consensus
Strong BuyWall Street consensus estimates — not a PMP forecast · Updated Aug 31, 2026
Analyst Recommendations36 analysts · 2026-08-01
15
16
5
Strong Buy 15Buy 16Hold 5Sell 0Strong Sell 0
Recent Market Moves
See all DXCM moves →| Date | Session | Price | Move | Z-Score |
|---|---|---|---|---|
| Aug 5 | Regular | $82.86 | -4.69% | -3.13 |
| Aug 5 | After-hours | $83.37 | -4.11% | -2.74 |
| Aug 3 | Regular | $86.83 | +4.05% | 2.70 |
| Aug 3 | After-hours | $87.33 | +4.65% | 3.10 |